SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-09-01 19:08
Tx date 2021-09-01
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$72,500
+500,000 vol
$0.145 each
11,958,800
Filed 2021-06-02 17:03
Tx date 2021-06-02
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$31,720
+200,000 vol
$0.1586 each
11,458,800
Filed 2021-04-28 18:17
Tx date 2021-04-27
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,900
+74,500 vol
$0.20 each
11,258,800
Filed 2021-04-28 18:15
Tx date 2021-04-27
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$35,055
+184,500 vol
$0.19 each
11,184,300
Filed 2021-04-28 18:14
Tx date 2021-04-27
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,585
+41,000 vol
$0.185 each
10,999,800
Filed 2021-04-28 17:58
Tx date 2017-02-25
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-90,000 vol
0
Filed 2021-04-28 17:47
Tx date 2021-04-27
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$185.00
+1,000 vol
$0.185 each
Filed 2021-04-28 17:47
Tx date 2021-04-27
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$185.00
+1,000 vol
$0.185 each
10,959,800
Filed 2021-04-05 17:49
Tx date 2021-04-01
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$187,500
+1,562,500 vol
$0.12 each
10,958,800
Filed 2021-04-05 17:48
Tx date 2021-04-01
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-187,500
-1,562,500 vol
$0.12 each
90,000
Filed 2021-04-05 17:33
Tx date 2021-03-31
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$7,500
+62,500 vol
$0.12 each
221,500
Filed 2021-04-05 17:30
Tx date 2021-03-31
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-62,500 vol
0
Filed 2021-03-24 20:15
Tx date 2014-12-18
$AQS
Aequus Pharmaceuticals Inc.
Clark, Chris
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+350,000 vol
350,000
Filed 2021-03-24 20:14
Tx date 2014-12-18
$AQS
Aequus Pharmaceuticals Inc.
Clark, Chris
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-04-15 15:32
Tx date 2014-12-18
$AQS
Aequus Pharmaceuticals Inc.
Clark, Chris
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-03-17 04:09
Tx date 2014-12-18
$AQS
Aequus Pharmaceuticals Inc.
Clark, Chris
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-17 01:31
Tx date 2021-02-15
$AQS
Aequus Pharmaceuticals Inc.
Lustig, Marc
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
350,000
Filed 2021-01-18 13:30
Tx date 2021-01-15
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,750
+70,000 vol
$0.125 each
9,396,300
Filed 2021-01-18 13:29
Tx date 2021-01-15
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$15,600
+130,000 vol
$0.12 each
9,326,300
Filed 2021-01-04 13:10
Tx date 2020-12-31
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,000
+100,000 vol
$0.11 each
9,196,300
Filed 2021-01-04 13:08
Tx date 2020-12-29
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,100
+100,000 vol
$0.101 each
9,096,300
Filed 2020-12-14 23:06
Tx date 2020-12-08
$AQS
Aequus Pharmaceuticals Inc.
Clark, Christopher John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+350,000 vol
800,000
Filed 2020-12-14 14:55
Tx date 2020-12-08
$AQS
Aequus Pharmaceuticals Inc.
Flowerday, Jason
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$36,750
+350,000 vol
$0.105 each
800,000
Filed 2020-12-11 13:43
Tx date 2020-12-08
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Holder: Fehr & Associates (Indirect Ownership)
Options
50 - Grant of options
$7,875
+75,000 vol
$0.105 each
150,000
Filed 2020-12-11 13:41
Tx date 2020-12-08
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$10,500
+100,000 vol
$0.105 each
275,000
Filed 2020-12-09 12:22
Tx date 2020-12-08
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$20,600
+200,000 vol
$0.103 each
8,996,300
Filed 2020-12-03 12:53
Tx date 2020-12-01
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$16,200
+150,000 vol
$0.108 each
8,796,300
Filed 2020-11-02 13:57
Tx date 2020-10-30
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,687
+21,500 vol
$0.125 each
8,646,300
Filed 2020-10-20 16:12
Tx date 2020-10-20
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$15,150
+150,000 vol
$0.101 each
8,624,800
Filed 2020-08-11 23:14
Tx date 2020-08-06
$AQS
Aequus Pharmaceuticals Inc.
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus

+312,500 vol
312,500
Filed 2020-08-11 23:11
Tx date 2020-02-01
$AQS
Aequus Pharmaceuticals Inc.
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-11 23:11
Tx date 2020-08-06
$AQS
Aequus Pharmaceuticals Inc.
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$50,000
+625,000 vol
$0.08 each
625,000
Filed 2020-08-11 23:09
Tx date 2020-02-01
$AQS
Aequus Pharmaceuticals Inc.
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-11 23:08
Tx date 2020-02-14
$AQS
Aequus Pharmaceuticals Inc.
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+350,000 vol
350,000
Filed 2020-08-11 23:06
Tx date 2020-02-01
$AQS
Aequus Pharmaceuticals Inc.
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-10 21:56
Tx date 2020-08-06
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus

+62,500 vol
62,500
Filed 2020-08-10 21:54
Tx date 2016-07-22
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-10 21:54
Tx date 2020-08-06
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$10,000
+125,000 vol
$0.08 each
159,000
Filed 2020-08-10 14:52
Tx date 2020-08-06
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
$187,500
+1,562,500 vol
$0.12 each
1,652,500
Filed 2020-08-10 14:45
Tx date 2020-08-06
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$250,000
+3,125,000 vol
$0.08 each
8,474,800
Filed 2020-06-10 11:46
Tx date 2020-06-09
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,910
+46,000 vol
$0.085 each
5,349,800
Filed 2020-06-10 11:44
Tx date 2020-06-09
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,320
+54,000 vol
$0.08 each
5,303,800
Filed 2020-06-10 11:43
Tx date 2020-06-08
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,000
+100,000 vol
$0.08 each
5,249,800
Filed 2019-05-23 12:25
Tx date 2019-03-15
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,925
-13,000 vol
$0.225 each
0
Filed 2017-12-12
Tx date 2017-12-07
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
175,000
Filed 2017-12-12
Tx date 2017-12-07
$AQS
Aequus Pharmaceuticals Inc.
Ball, Ian Richard
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+300,000 vol
440,000
Filed 2017-12-12
Tx date 2017-12-07
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Rodoula
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
100,000
Filed 2017-12-12
Tx date 2017-12-07
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+300,000 vol
540,000
Filed 2017-12-12
Tx date 2017-12-07
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+300,000 vol
1,724,337
Filed 2017-12-12
Tx date 2015-02-18
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Rodoula
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-12-12
Tx date 2017-12-07
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+452,941 vol
452,941
Filed 2017-12-12
Tx date 2015-02-18
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-12-11
Tx date 2017-12-06
$AQS
Aequus Pharmaceuticals Inc.
Clark, Christopher John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
450,000
Filed 2017-12-09
Tx date 2017-12-07
$AQS
Aequus Pharmaceuticals Inc.
Flowerday, Jason
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$19,500
+100,000 vol
$0.195 each
450,000
Filed 2017-09-21
Tx date 2017-09-18
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,040
+19,000 vol
$0.16 each
5,149,800
Filed 2017-09-21
Tx date 2017-09-18
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$47,770
+281,000 vol
$0.17 each
5,130,800
Filed 2017-09-13
Tx date 2017-09-12
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,125
+25,000 vol
$0.165 each
4,849,800
Filed 2017-08-02
Tx date 2017-07-28
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,255
+11,000 vol
$0.205 each
4,824,800
Filed 2017-07-14
Tx date 2017-07-12
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,450
+15,000 vol
$0.23 each
4,803,800
Filed 2017-07-14
Tx date 2017-07-14
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,250
+10,000 vol
$0.225 each
4,813,800
Filed 2017-06-21
Tx date 2017-06-20
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,120
+13,000 vol
$0.24 each
4,788,800
Filed 2017-06-21
Tx date 2017-06-16
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,327
+9,500 vol
$0.245 each
4,775,800
Filed 2017-06-21
Tx date 2017-06-16
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,120
+25,500 vol
$0.24 each
4,766,300
Filed 2017-05-05
Tx date 2017-05-05
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,500
+50,000 vol
$0.25 each
4,740,800
Filed 2017-05-05
Tx date 2017-05-03
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,465
+45,500 vol
$0.23 each
4,690,800
Filed 2016-11-16
Tx date 2016-11-16
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$405.00
+1,500 vol
$0.27 each
13,000
Filed 2016-10-21
Tx date 2016-10-20
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,160
+6,000 vol
$0.36 each
4,645,300
Filed 2016-10-06
Tx date 2016-09-13
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$10,200
+34,000 vol
$0.30 each
34,000
Filed 2016-10-06
Tx date 2016-07-22
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-26
Tx date 2016-09-23
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,385
+9,000 vol
$0.265 each
4,639,300
Filed 2016-09-26
Tx date 2016-09-23
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,250
+21,000 vol
$0.25 each
4,630,300
Filed 2016-09-19
Tx date 2016-09-19
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,610
+9,000 vol
$0.29 each
4,609,300
Filed 2016-09-19
Tx date 2016-09-19
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$285.00
+1,000 vol
$0.285 each
4,600,300
Filed 2016-09-13
Tx date 2016-09-13
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$249,090
+830,300 vol
$0.30 each
4,599,300
Filed 2016-08-02
Tx date 2016-07-22
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Holder: Fehr & Associates (Indirect Ownership)
Options
50 - Grant of options

+75,000 vol
75,000
Filed 2016-08-02
Tx date 2016-07-22
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Holder: Fehr & Associates (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-08-02
Tx date 2016-07-22
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+75,000 vol
75,000
Filed 2016-08-02
Tx date 2016-07-22
$AQS
Aequus Pharmaceuticals Inc.
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-30
Tx date 2016-05-20
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,585
-5,500 vol
$0.47 each
11,500
Filed 2016-05-30
Tx date 2016-05-06
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-460.00
-1,000 vol
$0.46 each
17,000
Filed 2016-05-06
Tx date 2016-05-06
$AQS
Aequus Pharmaceuticals Inc.
McAfee, Donald
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$18,800
+40,000 vol
$0.47 each
100,000
Filed 2016-05-06
Tx date 2015-07-28
$AQS
Aequus Pharmaceuticals Inc.
Ball, Ian Richard
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-06
Tx date 2016-05-06
$AQS
Aequus Pharmaceuticals Inc.
Ball, Ian Richard
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$65,800
+140,000 vol
$0.47 each
140,000
Filed 2016-05-06
Tx date 2016-05-03
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,369
+3,000 vol
$0.4566 each
6,076,458
Filed 2016-05-06
Tx date 2016-05-04
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,125
+2,500 vol
$0.45 each
6,078,958
Filed 2016-05-06
Tx date 2016-04-21
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$65,800
+140,000 vol
$0.47 each
Filed 2016-05-06
Tx date 2016-05-06
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$65,800
+140,000 vol
$0.47 each
1,424,337
Filed 2016-04-01
Tx date 2016-04-01
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,530
+3,000 vol
$0.51 each
6,073,458
Filed 2016-04-01
Tx date 2016-04-01
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,855
+3,500 vol
$0.53 each
6,070,458
Filed 2016-04-01
Tx date 2016-03-31
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,020
+2,000 vol
$0.51 each
6,066,958
Filed 2016-04-01
Tx date 2016-03-31
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,225
+2,500 vol
$0.49 each
6,064,958
Filed 2016-04-01
Tx date 2016-03-29
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$495.00
+1,000 vol
$0.495 each
6,062,458
Filed 2016-04-01
Tx date 2016-03-29
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,187
+2,500 vol
$0.475 each
6,061,458
Filed 2016-04-01
Tx date 2016-03-29
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,525
+7,500 vol
$0.47 each
6,058,958
Filed 2016-03-31
Tx date 2016-03-28
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,350
+5,000 vol
$0.47 each
3,769,000
Filed 2016-03-21
Tx date 2016-03-17
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$41,979
+83,958 vol
$0.50 each
6,051,458
Filed 2016-03-21
Tx date 2016-03-17
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,425
+3,000 vol
$0.475 each
5,967,500
Filed 2016-03-21
Tx date 2016-03-16
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,520
+12,000 vol
$0.46 each
5,964,500
Filed 2016-02-29
Tx date 2016-02-29
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,000
+6,000 vol
$0.50 each
3,764,000
Filed 2016-02-18
Tx date 2016-02-18
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,850
+10,000 vol
$0.485 each
3,758,000
Filed 2016-02-18
Tx date 2016-02-16
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,880
+12,000 vol
$0.49 each
3,748,000
Filed 2016-01-15
Tx date 2016-01-14
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,000
+10,000 vol
$0.50 each
5,952,500
Filed 2016-01-14
Tx date 2016-01-14
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,650
+5,000 vol
$0.53 each
5,942,500
Filed 2016-01-14
Tx date 2016-01-14
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,700
+5,000 vol
$0.54 each
5,937,500
Filed 2015-12-25
Tx date 2015-12-23
$AQS
Aequus Pharmaceuticals Inc.
Shahbazi, Hamed
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$129,250
+235,000 vol
$0.55 each
350,000
Filed 2015-12-18
Tx date 2015-12-11
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,734
+27,000 vol
$0.4346 each
5,932,500
Filed 2015-12-18
Tx date 2015-12-11
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,734
+27,000 vol
$0.4346 each
Filed 2015-11-30
Tx date 2015-11-26
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$610.00
+1,000 vol
$0.61 each
3,736,000
Filed 2015-11-30
Tx date 2015-11-25
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,360
+6,000 vol
$0.56 each
3,735,000
Filed 2015-11-23
Tx date 2015-11-23
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,600
+5,000 vol
$0.52 each
3,729,000
Filed 2015-11-17
Tx date 2015-11-13
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,000
+10,000 vol
$0.50 each
3,724,000
Filed 2015-11-17
Tx date 2015-11-13
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
70 - Acquisition or disposition (writing) of third party derivative
$3,640
+7,000 vol
$0.52 each
3,714,000
Filed 2015-11-17
Tx date 2015-11-11
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,000
+10,000 vol
$0.50 each
3,707,000
Filed 2015-11-17
Tx date 2015-11-11
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,350
+5,000 vol
$0.47 each
3,697,000
Filed 2015-11-16
Tx date 2015-11-12
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,500
+5,000 vol
$0.50 each
5,905,500
Filed 2015-11-12
Tx date 2015-11-12
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,000
+4,000 vol
$0.50 each
18,000
Filed 2015-11-06
Tx date 2015-11-04
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,000
+8,000 vol
$0.50 each
5,900,500
Filed 2015-11-06
Tx date 2015-11-03
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,000
+10,000 vol
$0.50 each
5,892,500
Filed 2015-11-06
Tx date 2015-11-04
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,020
+2,000 vol
$0.51 each
3,692,000
Filed 2015-11-06
Tx date 2015-11-04
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$250,000
+5,000 vol
$50.00 each
3,690,000
Filed 2015-11-06
Tx date 2015-11-03
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$250,000
+5,000 vol
$50.00 each
3,685,000
Filed 2015-11-06
Tx date 2015-11-02
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,160
+8,000 vol
$0.52 each
3,680,000
Filed 2015-10-07
Tx date 2015-07-28
$AQS
Aequus Pharmaceuticals Inc.
Ball, Ian Richard
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
3,259,200
Filed 2015-10-07
Tx date 2014-07-28
$AQS
Aequus Pharmaceuticals Inc.
Ball, Ian Richard
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-09-20
Tx date 2015-09-16
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$265.00
+500 vol
$0.53 each
5,882,500
Filed 2015-09-20
Tx date 2015-09-16
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,480
+12,000 vol
$0.54 each
5,882,000
Filed 2015-09-08
Tx date 2015-09-03
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,200
+4,000 vol
$0.55 each
3,672,000
Filed 2015-08-24
Tx date 2015-08-19
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,860
+3,000 vol
$0.62 each
3,668,000
Filed 2015-08-19
Tx date 2015-08-10
$AQS
Aequus Pharmaceuticals Inc.
Shahbazi, Hamed
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$13,750
+25,000 vol
$0.55 each
28,000
Filed 2015-08-16
Tx date 2015-08-13
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,900
+5,000 vol
$0.58 each
3,665,000
Filed 2015-08-16
Tx date 2015-08-11
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,850
+7,000 vol
$0.55 each
3,660,000
Filed 2015-07-17
Tx date 2015-07-14
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,240
+3,500 vol
$0.64 each
3,647,000
Filed 2015-07-17
Tx date 2015-07-14
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$945.00
+1,500 vol
$0.63 each
3,643,500
Filed 2015-07-17
Tx date 2015-07-16
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,080
+6,000 vol
$0.68 each
3,653,000
Filed 2015-06-18
Tx date 2015-06-15
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,080
+2,000 vol
$0.54 each
3,642,000
Filed 2015-06-18
Tx date 2015-06-16
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,500
+5,000 vol
$0.50 each
5,865,000
Filed 2015-06-18
Tx date 2015-06-15
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,640
+7,000 vol
$0.52 each
3,640,000
Filed 2015-06-18
Tx date 2015-06-16
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,450
+5,000 vol
$0.49 each
5,870,000
Filed 2015-06-15
Tx date 2015-06-15
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,849
+5,000 vol
$0.57 each
5,860,000
Filed 2015-06-15
Tx date 2015-06-15
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,050
+11,000 vol
$0.55 each
5,855,000
Filed 2015-06-15
Tx date 2015-06-15
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,860
+9,000 vol
$0.54 each
5,844,000
Filed 2015-06-12
Tx date 2015-06-09
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,950
+5,000 vol
$0.59 each
3,623,000
Filed 2015-06-12
Tx date 2015-06-11
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,699
+10,000 vol
$0.57 each
5,835,000
Filed 2015-06-12
Tx date 2015-05-21
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,704
+6,500 vol
$0.57 each
5,825,000
Filed 2015-06-12
Tx date 2015-05-15
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,994
+3,500 vol
$0.57 each
5,818,500
Filed 2015-06-12
Tx date 2015-06-12
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$900.00
+1,500 vol
$0.60 each
3,633,000
Filed 2015-06-12
Tx date 2015-06-12
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,994
+3,500 vol
$0.57 each
3,631,500
Filed 2015-06-12
Tx date 2015-06-10
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,200
+2,000 vol
$0.60 each
3,628,000
Filed 2015-06-12
Tx date 2015-06-10
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,770
+3,000 vol
$0.59 each
3,626,000
Filed 2015-06-09
Tx date 2015-06-08
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,720
+6,000 vol
$0.62 each
3,618,000
Filed 2015-06-09
Tx date 2015-06-03
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,490
+9,000 vol
$0.61 each
3,612,000
Filed 2015-05-27
Tx date 2015-05-27
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,840
+6,000 vol
$0.64 each
3,603,000
Filed 2015-05-27
Tx date 2015-05-25
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,200
+5,000 vol
$0.64 each
3,597,000
Filed 2015-05-27
Tx date 2015-05-25
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,260
+2,000 vol
$0.63 each
3,592,000
Filed 2015-05-22
Tx date 2015-05-21
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,880
+8,000 vol
$0.61 each
3,590,000
Filed 2015-05-22
Tx date 2015-05-21
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,180
+2,000 vol
$0.59 each
3,582,000
Filed 2015-05-19
Tx date 2015-05-19
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,500
+10,000 vol
$0.65 each
3,580,000
Filed 2015-05-19
Tx date 2015-05-15
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,000
+10,000 vol
$0.60 each
3,570,000
Filed 2015-05-14
Tx date 2015-05-13
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,130
+7,000 vol
$0.59 each
5,815,000
Filed 2015-05-14
Tx date 2015-05-14
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,000
+10,000 vol
$0.60 each
3,560,000
Filed 2015-05-11
Tx date 2015-05-01
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$600.00
+1,000 vol
$0.60 each
5,801,000
Filed 2015-05-11
Tx date 2015-05-04
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,709
+3,000 vol
$0.57 each
5,804,000
Filed 2015-05-11
Tx date 2015-05-08
$AQS
Aequus Pharmaceuticals Inc.
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,400
+4,000 vol
$0.60 each
5,808,000
Filed 2015-04-30
Tx date 2015-04-29
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$21,000
+35,000 vol
$0.60 each
3,535,000
Filed 2015-04-30
Tx date 2015-04-29
$AQS
Aequus Pharmaceuticals Inc.
Shahbazi, Hamed
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,800
+3,000 vol
$0.60 each
3,000
Filed 2015-04-30
Tx date 2015-03-16
$AQS
Aequus Pharmaceuticals Inc.
Shahbazi, Hamed
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-04-30
Tx date 2015-04-30
$AQS
Aequus Pharmaceuticals Inc.
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,000
+15,000 vol
$0.60 each
3,550,000
Filed 2015-04-30
Tx date 2015-04-29
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,400
+4,000 vol
$0.60 each
14,000